LINC00710: A Non-Protein Coding RNA Molecule with A Unique 3' End

Target Name: LINC00710

NCBI ID: G254312

LINC00710

Other Name(s): Long intergenic non-protein coding RNA 710, transcript variant 1 | long intergenic non-protein coding RNA 710

LINC00710: A Non-Protein Coding RNA Molecule with A Unique 3' End

LINC00710 is a non-protein coding RNA (ncRNA) molecule that has been identified by bioinformatics analysis as belonging to the LINC (long intergenic non-protein coding RNAs) family. This family ofncRNAs has been identified in a variety of organisms, including humans, and is characterized by the presence of a long intergenic region that is not covered by a protein coding gene.

One of the key features of LINC00710 is its unique 3' end, which is composed of a long uninterrupted sequence of uridine residues. This unique 3' end is thought to be a key factor in the stability and translation of LINC00710 RNA, as it allows the molecule to be processed by the cell's RNA-propping machinery.

Another notable feature of LINC00710 is its potential role as a drug target or biomarker. The unique 3' end of the molecule has been shown to be highly conserved across different organisms and species, which suggests that it may be a useful target for small molecules or other therapeutic compounds. Additionally, the fact that LINC00710 is a non-protein coding RNA also suggests that it may be a more stable and less risky drug or biomarker compared to proteins that are often targeted by drugs.

Furthermore, LINC00710 has been shown to play a role in a variety of cellular processes, including cell adhesion, migration and transcriptional regulation. LINC00710 has been shown to be involved in the regulation of theNotch signaling pathway, a pathway that plays a role in the development and maintenance of tissues and organs.

In addition to its potential role as a drug target or biomarker, LINC00710 also has potential as a therapeutic agent. The unique 3' end of the molecule has been shown to be highly conserved across different organisms and species, which suggests that it may be able to be used as a small molecule that can modulate the activity of other RNA molecules. Additionally, the fact that LINC00710 is a non-protein coding RNA also suggests that it may be a more stable and less risky therapeutic agent compared to proteins that are often targeted by drugs.

In conclusion, LINC00710 is a non-protein coding RNA molecule that has a unique 3' end that is highly conserved across different organisms and species. Its potential role as a drug target or biomarker, as well as its potential as a therapeutic agent make it an interesting candidate for further study. Further research is needed to fully understand the role of LINC00710 in cellular processes and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 710

The "LINC00710 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00710 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets